Life ScienceCompany
Meda has acquired 12 companies of its own. A total of 10 acquisitions came from private equity firms. It has also divested 1 asset.
Meda’s largest acquisition to date was in 2014, when it acquired Rottapharm for $3.1B. Meda has acquired in 3 different US states, and 4 countries. The Company’s most targeted sectors include life science (86%) and medical products (15%).
Join Mergr and gain access to Meda’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity8
- M&A Buy Activity7
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 4
- M&A Buy/Sell Connections 10
- M&A Advisors 2
Unlimited Searches
